An Exploratory Study on the Safety and Efficacy of Universal CAR-T Cells Targeting BCMA and CD19 in the Treatment of Refractory Autoimmune Diseases of the Nervous System. This evidence concerns the gene CD19 and autoimmune disorder of the nervous system.